BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: [DOI: 10.1101/2020.12.14.422714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
Number Citing Articles
1 Pacheco-garcía U, Serafín-lópez J. Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity. Vaccines 2023;11:655. [DOI: 10.3390/vaccines11030655] [Reference Citation Analysis]
2 Akter A, Clemente-Casares X. COVID-19: The Many Ways to Hurt Your Heart. Viruses 2023;15. [PMID: 36851629 DOI: 10.3390/v15020416] [Reference Citation Analysis]
3 Brechbühl J, Ferreira F, Lopes AC, Corset E, Gilliand N, Broillet MC. Ocular Symptoms Associated with COVID-19 Are Correlated with the Expression Profile of Mouse SARS-CoV-2 Binding Sites. Viruses 2023;15. [PMID: 36851565 DOI: 10.3390/v15020354] [Reference Citation Analysis]
4 Righetto I, Gasparotto M, Casalino L, Vacca M, Filippini F. Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota in the Gut-Brain Axis. Biomolecules 2023;13. [PMID: 36671555 DOI: 10.3390/biom13010169] [Reference Citation Analysis]
5 Morgan MS, Yan K, Le TT, Johnston RA, Amarilla AA, Muller DA, McMillan CLD, Modhiran N, Watterson D, Potter JR, Sng JDJ, Lor M, Paramitha D, Isaacs A, Khromykh AA, Hall RA, Suhrbier A, Rawle DJ, Hobson-Peters J. Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern. Viruses 2022;15. [PMID: 36680179 DOI: 10.3390/v15010139] [Reference Citation Analysis]
6 Amruta N, Ismael S, Leist SR, Gressett TE, Srivastava A, Dinnon KH 3rd, Engler-Chiurazzi EB, Maness NJ, Qin X, Kolls JK, Baric RS, Bix G. Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice. Viruses 2022;15. [PMID: 36680154 DOI: 10.3390/v15010114] [Reference Citation Analysis]
7 Tailor N, Warner BM, Griffin BD, Tierney K, Moffat E, Frost K, Vendramelli R, Leung A, Willman M, Thomas SP, Pei Y, Booth SA, Embury-Hyatt C, Wootton SK, Kobasa D. Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene. Viruses 2022;15. [PMID: 36680125 DOI: 10.3390/v15010085] [Reference Citation Analysis]
8 Zhang L, Zhang Y, Qin X, Jiang X, Zhang J, Mao L, Jiang Z, Jiang Y, Liu G, Qiu J, Chen C, Qiu F, Zou Z. Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein. Crit Care 2022;26:171. [DOI: 10.1186/s13054-022-04034-9] [Reference Citation Analysis]
9 Lee KS, Wong TY, Russ BP, Horspool AM, Miller OA, Rader NA, Givi JP, Winters MT, Wong ZY, Cyphert HA, Denvir J, Stoilov P, Barbier M, Roan NR, Amin MS, Martinez I, Bevere JR, Damron FH. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice.. [DOI: 10.1101/2022.01.18.476863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Horspool AM, Ye C, Wong TY, Russ BP, Lee KS, Winters MT, Bevere JR, Kieffer T, Martinez I, Sourimant J, Greninger A, Plemper RK, Denvir J, Cyphert HA, Torrelles J, Martinez-Sobrido L, Damron FH. SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy. bioRxiv 2021:2021. [PMID: 33972945 DOI: 10.1101/2021.05.05.442784] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
11 Rawle DJ, Le TT, Dumenil T, Yan K, Tang B, Bishop C, Suhrbier A. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.. [DOI: 10.1101/2021.02.09.430547] [Reference Citation Analysis]
12 Carossino M, Montanaro P, O'Connell A, Kenney D, Gertje H, Grosz KA, Kurnick SA, Bosmann M, Saeed M, Balasuriya UBR, Douam F, Crossland NA. Fatal neuroinvasion of SARS-CoV-2 in K18-hACE2 mice is partially dependent on hACE2 expression. bioRxiv 2021:2021. [PMID: 33469581 DOI: 10.1101/2021.01.13.425144] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 11.5] [Reference Citation Analysis]